Gardner Lewis Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Gardner Lewis Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,000	Closed	-$929K	–	88
2021 Q4	$929K	Buy	+10,000	New	+$659K	0.17%	67

Gardner Lewis Asset Management's ARNA Position: Q1 2022 in Review

Gardner Lewis Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 10,000 shares — an estimated $929K sold.

Gardner Lewis Asset Management first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $929K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Gardner Lewis Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Gardner Lewis Asset Management sold 10,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $929K.
Gardner Lewis Asset Management first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Gardner Lewis Asset Management's Arena Pharmaceuticals Inc position peaked at $929K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Gardner Lewis Asset Management's 13F filing for Q1 2022, filed 11 May 2022.